Skin Diagnostics Group, PC

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Skin Diagnostics Group, PC - overview

Established

2009

Location

Birmingham, AL, US

Primary Industry

Healthcare

About

Based in Alabama, US, and founded in 2009, Skin Diagnostics Group, PC operates as a dermatopathology company that was founded by its current CEO, Dr. Alan Long. The company was acquired by PathGroup, Inc. in 2021.


The company provides diagnostics, laboratory, personalized client, and direct immunofluorescence services.


Current Investors

PGI Holdings, Inc.

Primary Industry

Healthcare

Sub Industries

Diagnostic, Medical & Imaging Laboratories, Dermatology

Website

www.skindxgroup.com

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Skin Diagnostics Group, PC - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedSkin Diagnostics Group, PC-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.